NVCR - NovoCure Limited (NVCR) CEO Asaf Danziger on Q2 2021 Results - Earnings Call Transcript

NovoCure Limited (NVCR) Q2 2021 Earnings Conference Call July 29, 2021 08:00 AM ET Company Participants Ingrid Goldberg - Vice President Finance & Investor Relations Bill Doyle - Executive Chairman Asaf Danziger - Chief Executive Officer Ashley Cordova - Chief Financial Officer Uri Weinberg - Chief Science Office Pritesh Shah - Chief Commercial Officer Conference Call Participants Jason Bednar - Piper Sandler Cory Kasimov - JPMorgan Difei Yang - Mizuho Securities Vijay Kumar - Evercore ISI Greg Fraser - Truist Securities Presentation Operator Good day, ladies and gentlemen. Thank you for standing by. Welcome to the NovoCure Second Quarter 2021 Earnings Conference Call. At this time, all participants lines are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference may be recorded. [Operator Instructions] I would now like to hand the conference over to one of your

For further details see:

NovoCure Limited (NVCR) CEO Asaf Danziger on Q2 2021 Results - Earnings Call Transcript